Moreover, these mice developed early onset metabolic syndromes, including hypertension, dyslipidemia, and hyperinsulinemia, suggesting a role of Slc2a9 in regulating enterocyte urate clearance (DeBosch et al., 2014). This evidence concerns the gene SLC2A9 and metabolic syndrome.